| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,142,759 | 1,468,349 | 1,431,776 | 1,311,908 | | Cost of Revenue | 665,287 | 816,835 | 805,533 | 740,178 | | | Gross Profit | 477,472 | 651,514 | 626,243 | 571,730 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 107,343 | 129,101 | 122,648 | 116,914 | | Non Recurring | (17,297) | 140,069 | 10,875 | 5,227 | | Others | 161,905 | 184,520 | 168,996 | 155,366 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 225,521 | 197,824 | 323,724 | 294,223 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 2,069 | | Earnings Before Interest And Taxes | 225,521 | (32,010) | 332,208 | 287,808 | | Interest Expense | 67,078 | 26,329 | 25,506 | 21,676 | | Income Before Tax | 158,443 | (58,339) | 306,702 | 266,132 | | Income Tax Expense | 33,273 | 25,654 | 96,403 | 71,771 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 125,170 | (83,993) | 210,299 | 194,361 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 125,170 | (83,993) | 210,299 | 194,361 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $125,170 | ($83,993) | $210,299 | $194,361 |
|
0.45% Nasdaq 
0.20%
Income Statement
